FATE (FATE)
Quantitative Summary
DeterministicBelow-average fundamentals indicated by Piotroski score of 1/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in FATE to visualize passive redemption contagion across ETFs and collateral stocks.
If FATE (FATE) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Eli Lilly & Co. (LLY) as the most exposed collateral stock, sharing 1 ETFs with FATE. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
FATE Ownership Dynamics
ETFs with Highest FATE Exposure
Float lock-up computed from 1 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-07 | 121,810 | $2.29 | $278,944.9 |
| 2026-04-29 | 497 | $1.30 | $646.1 |
| 2026-04-28 | 36,960 | $1.31 | $48,417.6 |
| 2026-04-13 | 6,806 | $1.24 | $8,439.44 |
| 2026-03-24 | 31 | $1.15 | $35.65 |
| 2026-03-17 | 794 | $1.16 | $921.04 |
| 2026-02-26 | 4,127 | $1.48 | $6,107.96 |
| 2026-02-24 | 265 | $1.51 | $400.15 |
| 2026-02-11 | 427 | $1.09 | $465.43 |
| 2026-02-06 | 16 | $1.05 | $16.8 |
| 2026-02-04 | 1,591 | $1.16 | $1,845.56 |
| 2025-12-31 | 1,033 | $0.98 | $1,012.34 |
| 2025-12-29 | 11,343 | $1.00 | $11,343 |
| 2025-12-24 | 10,539 | $0.98 | $10,328.22 |
| 2025-12-16 | 68 | $1.12 | $76.16 |
| 2025-12-12 | 104 | $1.11 | $115.44 |
| 2025-12-10 | 2,668 | $1.05 | $2,801.4 |
| 2025-11-24 | 2,481 | $1.03 | $2,555.43 |
| 2025-11-14 | 16,372 | $0.99 | $16,208.28 |
| 2025-11-12 | 2,824 | $1.12 | $3,162.88 |
| 2025-11-06 | 425,600 | $1.09 | $463,904 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare FATE to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.